Waldenström macroglobulinemia: from biology to treatment.
about
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testingIncidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.Ibrutinib for the treatment of Waldenström macroglobulinemia.Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression.Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.The comprehensive clinical management of multiple myeloma and related-plasma cell disorders.
P2860
Q26784600-41547AA6-C294-4DBC-96A6-D917F00D9407Q36337598-7E2107D4-B25E-4B22-A83B-D543437E295BQ36533710-76DCEF4B-40EC-48E6-8042-2E9F636DFDA4Q38542260-BFFB6040-7DE9-40A6-834C-194A43CF8B89Q38971845-B7AC217F-8DD6-41A1-AA3E-689F96CAB8E5Q41286883-CA11DD28-34A8-4F88-B9B2-4E9A77A4A69FQ44829958-2EE0AF65-F7B2-43DA-B747-EA882FBD3F9FQ47608445-B9A39E4E-7CA7-41C4-9D95-455F0960D5A9
P2860
Waldenström macroglobulinemia: from biology to treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Waldenström macroglobulinemia: from biology to treatment.
@en
type
label
Waldenström macroglobulinemia: from biology to treatment.
@en
prefLabel
Waldenström macroglobulinemia: from biology to treatment.
@en
P2093
P2860
P1476
Waldenström macroglobulinemia: from biology to treatment.
@en
P2093
Houry Leblebjian
Ilyas Sahin
Irene M Ghobrial
Steven P Treon
P2860
P304
P356
10.1586/17474086.2014.871494
P577
2014-01-03T00:00:00Z